Life Sciences Nova Scotia
  • About
    • Who We Are
    • What we do
    • Why work in Nova Scotia?
    • Contact us
  • Members
    • Member Directory
    • Member Benefits
    • Become a member
  • Resources
    • Member Programs
    • News and success stories
    • PetriDish Job Board
  • Events
    • Events
    • BioPort Atlantic
    • Atlantic Precision Medicine Conference
  • Podcast
Select Page

NSBI : A spotlight on how some Nova Scotian companies are pivoting operations to help the fight against COVID-19

by Shana Cristoferi | Apr 28, 2020 | IMV Inc., News, Spring Loaded Technology

Read original here From producing protective equipment and hand sanitizer, to innovating medical technology, here’s how some Nova Scotia companies are changing the way they do business. In response to COVID-19, IMV initiated the development of a vaccine. The...

First Patient Dosed in Phase 1 Clinical Trial Evaluating Neoepitopes Formulated in IMV’s DPX Delivery Platform in Ovarian Cancer Patients

by administrator | Jan 17, 2019 | IMV Inc., Members, News

Read original release here January 17, 2019 at 7:05 AM EST DARTMOUTH, Nova Scotia, Jan. 17, 2019 (GLOBE NEWSWIRE) — IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that the first patient has been treated in the...
Next Entries »

Recent Posts

  • Bioteem40 Selected as Finalist for INMC Pitch Competition
  • Sona Nanotech’s Cancer Therapy Shows Potential in New Study
  • Twelve Start-ups Selected for First Cohort of 2026-2027 Accelerate
  • Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States
  • ABK Biomedical Closed $35M Financing Round in 2025
No comments to show.
[buddybot_chat id=1]

Life Sciences Nova Scotia is the organization to help fuel your success.

Join today
  • WHO WE ARE
  • EVENTS
  • MEMBER PROGRAMS
  • CONTACT US
  • MEMBERS
  • NEWS & SUCCESS STORIES
  • Follow
  • Follow